Navigation Links
Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
Date:11/8/2010

PARIS, Nov. 8, 2010 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has sent a letter to Genzyme Corporation (Nasdaq: GENZ) requesting that Genzyme clarify its position on a number of potential Board actions raised in Genzyme's Schedule 14D-9.

Sanofi-aventis' letter also notes that it is encouraged by Genzyme's decision to "probe and evaluate alternatives" including contacting third parties but observes that sanofi-aventis has not been contacted by Genzyme or its advisors. Sanofi-aventis continues to remain interested in working with Genzyme on a constructive basis and is committed to a mutually agreeable transaction.  

Below is the full text of the letter that was sent to Genzyme, which is also being filed with the U.S. Securities and Exchange Commission.November 8, 2010VIA EMAIL, TELECOPIER AND DHLMr. Henri TermeerChairman, President and Chief Executive OfficerGenzyme Corporation500 Kendall StreetCambridge, Massachusetts 02147USADear Henri,

Now that Genzyme's third-quarter earnings have been released, you have had the opportunity to speak to shareholders regarding Genzyme's business and prospects (including the detailed presentation to analysts and investors on October 22) and the market has had a chance to digest and react to all of this information, we would again like to request that you meet with us to discuss our proposal to acquire Genzyme.  We continue to believe that our proposal is compelling for your shareholders and would provide them with immediate and substantial value that reflects the potential of Genzyme's business and pipeline.  

You have publicly disclosed that Genzyme's Board has authorized management and the company's advisors to "probe and evaluate alternatives" for Genzyme and its assets, inclu
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
2. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
3. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
4. Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
5. Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance
6. European Hospital Anticoagulant Market Dominated by Sanofi-Aventiss Clexane
7. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
8. Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
9. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
10. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
11. Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... are used to develop, manufacture and sell enzymes and ... industrial enzyme industries, announced today that it will report ... 30, 2014 after market close on Thursday, August 14, ... at 5:00 p.m. Eastern Time to discuss those results. ...
(Date:7/31/2014)... July 31, 2014  Sorrento Therapeutics, Inc. (NASDAQ: ... Amar Singh , Chief Business Officer and Executive Vice President. ... on July 30. "Sorrento is deeply saddened and ... Our immediate thoughts go to Amar,s family and friends," said ... Officer. Mr. Singh joined Sorrento in January ...
(Date:7/31/2014)... Xencor Inc. (NASDAQ: XNCR ... antibodies for the treatment of autoimmune diseases, asthma ... results for the second quarter ended June 30, 2014 ... "In the second quarter, we presented ... International Conference (ATS) demonstrating three novel mechanisms of ...
Breaking Medicine Technology:Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3Sorrento Announces the Unexpected Death of its Chief Business Officer 2Xencor Reports Second Quarter 2014 Financial Results 2Xencor Reports Second Quarter 2014 Financial Results 3Xencor Reports Second Quarter 2014 Financial Results 4Xencor Reports Second Quarter 2014 Financial Results 5Xencor Reports Second Quarter 2014 Financial Results 6Xencor Reports Second Quarter 2014 Financial Results 7Xencor Reports Second Quarter 2014 Financial Results 8
... 2011 The ophthalmic therapeutics company Xcovery Vision announced ... and Dr. Ken Mandell, President and COO, will be ... Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale Florida, May ... Serial Entrepreneur recounts his repeated success as founder ...
... KINGSTOWN, R.I., April 25, 2011 On Wednesday, April ... Island Congressman James R. Langevin, Governor Lincoln Chafee, Lieutenant ... laboratory tour and luncheon at its headquarters at 211 ... April 28 Attorney General Peter F. Kilmartin will tour ...
Cached Medicine Technology:Xcovery Vision Founders to Speak at ARVO 2011 2Dominion Diagnostics Celebrates National Medical Laboratory Professionals Week with Rhode Island Elected Officials 2
(Date:8/2/2014)... Apervi, the provider of secure ... engineering for big data, announced today that Conflux ... first Enterprise data engineering Platforms to be certified ... founded by the creators of Spark, recently announced ... encourage new development on the distributed, in-memory cluster-computing ...
(Date:8/2/2014)... When the Black Hat conventioneers descend on ... one thing can be always counted on, plenty of FUD ... uncertainty and doubt. The run-up has already made its ... by Reuters on July 31st about how hackers could ... to successfully infect a system with malware, completely undetected, by ...
(Date:8/1/2014)... August 01, 2014 The Judicial Panel ... that testosterone replacement therapy caused strokes, heart attacks, and ... designated Judge Matthew F. Kennelly as the transferee judge ... to the Chicago-based federal court. , As one of ... of appointing committees of attorneys who will move the ...
(Date:8/1/2014)... By Barbara Bronson Gray ... People who are obese and work in manufacturing jobs may have ... suggests. In a study of 32 people -- half were ... obese had endurance times that were about 60 percent longer. ... in task performance. Being older -- 50 to ...
(Date:8/1/2014)... 01, 2014 As it continues to ... women who allegedly experienced the spread of uterine cancers ... surgeries, Bernstein Liebhard LLP notes the growing reaction to ... power morcellators marketed by its Ethicon, Inc. unit from ... York Times, some critics of the company said they ...
Breaking Medicine News(10 mins):Health News:Databricks Certifies Apervi Conflux Director TM on Spark, Supercharging the Data to Insight Journey 2Health News:Databricks Certifies Apervi Conflux Director TM on Spark, Supercharging the Data to Insight Journey 3Health News:Black Hat USA 2014 Will Again Stress Need for Security Basics with Glimpse of What May Lie Ahead 2Health News:Black Hat USA 2014 Will Again Stress Need for Security Basics with Glimpse of What May Lie Ahead 3Health News:Black Hat USA 2014 Will Again Stress Need for Security Basics with Glimpse of What May Lie Ahead 4Health News:Black Hat USA 2014 Will Again Stress Need for Security Basics with Glimpse of What May Lie Ahead 5Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4
... depends on not just the particular strain of a pathogen, ... its host, according to new research results. Scientists from ... Agriculture,s Agricultural Research Service (USDA ARS) published the results today ... demonstrates that the pattern of gene regulation--how a cell determines ...
... recommendations to ensure that Medicare beneficiaries have access to ... College of Physicians (ACP). The new policy paper, ... released at Internal Medicine 2012, ACP,s annual scientific meeting. ... advantages and disadvantages of proposals to reform Medicare in ...
... News) -- American children are being exposed to background ... finds. For the study, researchers surveyed over ... 8 months to 8 years old. After taking other ... race, age and family income, the researchers also found ...
... By Serena Gordon HealthDay Reporter , FRIDAY, April ... juvenile open-angle glaucoma, A.J. Esguerra said he,s tried not to let ... not the end of the world," said Esguerra, now 23 and ... activities, and I look at it as just one other thing ...
... mysterious, difficult-to-diagnose, and potentially deadly disease that was ... if treatment is started within the first month ... by researchers from the Perelman School of Medicine ... 565 cases of this recently discovered paraneoplastic condition, ...
... of more effective cancer drugs could be a step ... Medical School, of how an inbuilt ,security check, operates ... chromosomes. , Most cells in our bodies contain ... identities. The process of chromosome segregation is monitored by ...
Cached Medicine News:Health News:History is key factor in plant disease virulence 2Health News:History is key factor in plant disease virulence 3Health News:Internal medicine physician specialists release policy paper on reforming Medicaid 2Health News:Internal medicine physician specialists release policy paper on reforming Medicaid 3Health News:Internal medicine physician specialists release policy paper on reforming Medicaid 4Health News:U.S. Children Exposed to Hours of Background TV Daily 2Health News:For Some, Glaucoma Strikes at a Young Age 2Health News:Early treatment improves outcomes in rare, often undiagnosed form of encephalitis 2Health News:Warwick scientists uncover how 'checkpoint' proteins bind chromosomes 2
... high resolution diagnostic test for cholesterol components which ... test procedure is simple and can be done ... is clearly flagged. A color coded profile is ... in red and the good HDL in green. ...
... intended as a means of ... assay methods. This ready-to-use, three-level ... significant levels of ammonia and ... for the following instruments: AU ...
... This control is designed for monitoring ... convenient for routine and stat testing and ... Assay values are included for most frequently ... most major chemistry analyzers including: Aeroset, AU ...
... This control is designed to validate visual ... the dipstick into the control the same ... feature is the addition of creatinine and microalbumin. ... results for hCG for early pregnancy detection test ...
Medicine Products: